TELIX PHARMACEUTIC earnings per share and revenue

TLX1/N earnings per share for the last semiannual are 1.07 MXN whereas the estimation was 1.65 MXN which accounts for -35.27% surprise. Company revenue for the same period amounts to 4.45 B MXN despite the estimated figure of 4.41 B MXN. Estimated earnings per share for the next semiannual are 1.29 MXN, and revenue is expected to reach 5.11 B MXN. Also watch annual changes over time to get a bigger picture of TLX1/N earnings per share and revenue dynamics.